CTRI/2021/11/038197
Not yet recruiting
未知
A comparative study of safety, efficacy and correlation with non-invasive break up time using two fluorescein dyes in subjects undergoing dry eye evaluation for pre-refractive surgery work up
BioTech Vision Care Pvt Ltd0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: H048- Other disorders of lacrimal system
- Sponsor
- BioTech Vision Care Pvt Ltd
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Any patient presenting to refractive surgery clinic for refractive surgery clinic for refractive surgery work up within the age group of 20\-40 years with normal ocular surface.
- •2\. Clear corneas without scarring, opacities, or vascularization as determined by bio microscopic examination; normal puncta without punctal plugs or punctal stenosis; and the absence of any corneal disease or dystrophy
- •3\. Able to give written consent form
Exclusion Criteria
- •1\. Any patient of known ocular surface abnormality or corneal abnormality
- •2\. History of ocular surgery or corneal injury
- •3\. Active infection or allergy
- •4\. Conjunctival abnormality other than mild pinguecula
- •5\. Current use of any ocular medication, including antihistamines
- •6\. Use of artificial tear preparations 2 hours prior to examination
- •7\. Use of any ocular ointment, swimming in chlorinated water or 24 hours prior to examination
- •8\. Contact Lens wearers\- Soft contact Lens \<48 hours, rigid gas permeable lens \<2 weeks
- •9\. Patient on any ocular medications
- •10\. Any patient having known hypersensitivity to Fluorescein dye
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Comparison of the efficacy and safety of tamsulosin OCAS with tamsulosin MR and placebo in improving lower urinary tract symptomsIRCT20100817004582N8rology Research Centre, Guilan University of Medical Sciences260
Completed
Phase 4
Comparison of the seizure drug levetiracetam with controlled release carbamazepine in new focal seizure patientsHealth Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onsetHealth Condition 2: G402- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizuresHealth Condition 3: G401- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizuresCTRI/2019/05/018990Institutional sponsored74
Active, not recruiting
Not Applicable
Dexmedetomedine intravenous sedation on patients with and without Beta blockersHealth Condition 1: null- Retinal Disorder Patients requiring SurgeryHealth Condition 2: H431- Vitreous hemorrhageCTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1IRCT20130812014333N145Kermanshah University of Medical Sciences80
Recruiting
Phase 3
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19IRCT20130812014333N147Kermanshah University of Medical Sciences80